Category: Patent Litigation
-
Valtrus Innovations expands data center-focused campaign with multiple district court complaints asserting former HPE patents
Meanwhile, Starbucks’ declaratory judgment and anti-troll actions against Valtrus in Washington have been terminated.
-
Canadian Solar, Maxeon settle U.S. patent dispute
The Eastern District of Texas has dismissed Maxeonâs suit against Canadian Solar with prejudice, while the Federal Circuit has vacated the relevant portion of a PTAB decision relating to Maxeon’s remaining claim, resolving the case in Canadian Solarâs favor.
-
Zoom gets dialed in to Delaware suit as PulseLink files additional complaint over patents acquired from Avaya
It’s the second complaint that PAE PulseLink Systems LLC has filed against Zoom, following one in the Eastern District of Texas earlier this year.
-
Munich court consolidates FRAND framework for SEP licensing disputes
The Munich I Regional Courtâs new FRAND guidelines consolidate the 7th Civil Chamberâs approach to licensing willingness, implementer conduct and substantive review of SEP-holder offers into a single roadmap for future disputes.
-
Nokia and others share why Brazil is becoming a bigger part of their global patent strategies
Judges, experts, and attorneys shared their perspectives during Licks Attorneysâ ICT Patent Litigation Seminar on Technical and Scientific Evidence 2026.
-
German Federal Patent Court leans toward invalidating Malikie patent asserted against Xiaomi in Munich
Germanyâs Federal Patent Court has signaled it will likely invalidate a Malikie patent Xiaomi is fighting in a Munich infringement case, though the opinion is preliminary and non-binding.
-
UPC Court of Appeal upholds Abbottâs glucose sensor patent: rejects Sibioâs added matter, inventive step attacks
The UPC Court of Appeal has dismissed Sibioâs bid to revoke Abbottâs continuous glucose monitor patent, confirming its own earlier finding from a related injunction case and issuing two headnotes that will guide how the court treats omitted features in future added matter disputes.
-
Chinaâs top court overturns Nefecon generic PI despite U.S. Paragraph III-style no-launch pledgeÂ
A Chinese generic of Nefecon obtained formal approval after promising not to launch until patent expiry, then used that approval to seek procurement listings. Chinaâs top court nevertheless held that the broken Paragraph III-style pledge was a regulatory breach – not an admission of patent infringement.
-
Federal Circuit affirms invalidation of Nielsenâs audience-measurement patent, backs PTABâs âreasonably pertinentâ prior art finding
The Federal Circuit affirmed a PTAB ruling invalidating Nielsenâs audience-measurement patent, holding that a facial-expression research paper qualified as âreasonably pertinentâ prior art despite coming from a different research field.
-
EWHC hinders Accordâs plans to launch Entresto competing product in Novartis patent dispute
Mr. Justice Meade of the High Court of Justice for England & Wales has held that all of Accordâs âattacksâ on a Novartis Entresto patent have failed, and its own intended competing product would infringe the defendantâs supplementary protection certificate.